Patents Examined by Zohreh Fay
-
Patent number: 11141448Abstract: A weight loss composition including banaba leaf extract, apple fruit extract, Rhodiola root extract, zinc chelate, and magnesium chelate are described. The weight loss composition may further include gardenia fruit extract, chromium chelate, Salacia extract, berberine, inositol, or mixtures thereof. Embodiments are also directed to a bulk food product and a weight management plan, which may be used in conjunction with the weight loss composition. Embodiments are also directed to kits and methods of use for treating or preventing obesity, promoting weight loss, and improving insulin resistance.Type: GrantFiled: May 7, 2020Date of Patent: October 12, 2021Assignee: GOLO LLCInventors: Christopher Brian Lundin, Terry Shirvani
-
Patent number: 11135162Abstract: The invention relates to a pharmaceutical composition in the form of an aqueous solution, preferably a syrup, containing inosine pranobex and zinc gluconate, characterised in that it contains a sweetener selected from the group of disaccharides, preferably sucrose or/and from the group of polyols, preferably maltitol, a solubilizer from the group of hydroxy alcohols or mixtures thereof, preferably propylene glycol, glycerol, preservatives selected from the group of parahydroxybenzoic acid esters and mixtures thereof, preferably methyl parahydroxybenzoate, propyl parahydroxybenzoate, a sweetener, preferably sodium saccharine or sucralose, and pH regulators in the range from 5.7 to 12.0 preferably aroma, and a method of preparation thereof.Type: GrantFiled: June 21, 2018Date of Patent: October 5, 2021Assignee: AFLOFARM FARMACJA POLSKA SP. Z O. O.Inventors: Hanna Wahl, Marek Dąbrowa, Anna Ostrowska, Malgorzata Kowalska - Parteka, Jaroslaw Pasiński, Arkadiusz Madejczyk
-
Patent number: 11135146Abstract: The present disclosure provides biophotonic topical compositions, kits and their uses. In some aspects, the biophotonic topical compositions of the present disclosure comprise a first chromophore, a salt selected from one or more bicarbonate or carbonate salts or a combination of the foregoing salts, and one or more gelling agents. In some aspects, the biophotonic topical compositions of the present disclosure comprise a first chromophore, one or more polyols, and one or more gelling agents. The biophotonic compositions of the present disclosure do not include an oxidant selected from the group consisting of a peroxide, a peroxy acid, hydrogen peroxide, carbamide peroxide, an alkali metal peroxide, an alkali metal percarbonate, peroxyacetic acid, and an alkali metal perborate. The biophotonic compositions are useful for promoting wound healing and skin rejuvenation, as well as treating acne and various skin disorders.Type: GrantFiled: December 28, 2016Date of Patent: October 5, 2021Assignee: KLOX TECHNOLOGIES LIMITEDInventors: Francesco Bellini, David Ohayon, Remigio Piergallini, Nikolaos Loupis, William Curtis
-
Patent number: 11123429Abstract: A method and system for administering pharmaceutical agents to a subject is provided. The system includes a course of treatment regimen, which includes a prescribed order of medicine amounts for periodic administration to the subject in the prescribed order. The amount of medicine includes a dose of at least one active pharmacological agent (APA) and an amount of at least one non-active pharmacological agent (NPA). The NPA provides at least one non-visual sensory cue. The dosage amounts of the APA contained within the amounts of medicine periodically administered in the prescribed order are varied within the course of treatment regimen, and the amount of the NPA contained within the amounts of medicine periodically administered in the prescribed order are held constant within the course of treatment regimen.Type: GrantFiled: February 10, 2020Date of Patent: September 21, 2021Inventors: Joshua D. Levine, Robert A. Levine
-
Patent number: 11124612Abstract: Described herein are flash nanoprecipitation methods capable of encapsulating hydrophobic molecules, hydrophilic molecules, bioactive protein therapeutics, or other target molecules in amphiphilic copolymer nanocarriers.Type: GrantFiled: April 10, 2020Date of Patent: September 21, 2021Assignee: Northwestern UniversityInventors: Evan A. Scott, Sean D. Allen
-
Patent number: 11116714Abstract: The present invention generally relates to skin care and, in particular, to systems and methods for treating and/or preventing acne. Acne is believed to be caused by a combination of factors, including Propionibacterium acnes bacteria, excess sebum production, and inflammation from the immune response (e.g., in response to P. acnes). Certain aspects of the invention are thus directed to one or more compositions that collectively target these factors, although it should be understood that a single composition may target more than one factor at a time. For instance, in one set of embodiments, a treatment may include a first composition that cleans the skin, a second composition that contains growth inhibitor of P. acnes (e.g., for use during the day), and a third composition that inhibits sebum production (e.g., for use during the night). One or more of these may contain other components, such as anti-inflammatory agents, moisturizers, topical anti-microbial agents (e.g., salicylic acid), or the like.Type: GrantFiled: April 15, 2020Date of Patent: September 14, 2021Assignee: N.V. Perricone LLCInventor: Christopher Cain Caires
-
Patent number: 11110048Abstract: Several embodiments disclosed herein relate to formulations having antimicrobial and/or sanitizing effects, and uses of the same. In particular, the formulations and methods of using same provide, in several embodiments, an immediate and a persistent antimicrobial effect against a broad spectrum of microorganisms.Type: GrantFiled: January 6, 2020Date of Patent: September 7, 2021Assignee: INNOVATIVE BIODEFENSE, INC.Inventors: Jesse Cozean, Colette Cozean, Susan Goldsberry
-
Patent number: 11110050Abstract: A method for treating hair comprising applying primer(s) and cationic polymer(s) onto a user's hair for improving the styling of the hair in a more manageable and reliable manner and for enhancing the stability of the final style obtained.Type: GrantFiled: October 5, 2018Date of Patent: September 7, 2021Assignee: WELLA OPERATIONS US, LLCInventors: Lars Siegfried Dahne, Mathias Kurt Herrlein, Tatjana Schaefer, Judith Hagios, Mandy Hecht, Moritz Klickermann
-
Patent number: 11103450Abstract: A polyfunctional radical scavenger hydrogel formulation providing extended protection of the extracellular space within a wound site. The polyfunctional radical scavenger hydrogel formulation is generally formed from a hydrogel, a first radical scavenger and a second radical scavenger differing from the first radical scavenger with respect to at least one property. A portion of the first radical scavenger included with the formation and/or second radical scavenger included within the formulation may be dissolved, suspended and/or bonded to a polymer of the hydrogel.Type: GrantFiled: May 5, 2020Date of Patent: August 31, 2021Assignee: RXOS Medical Inc.Inventors: Richard M. Millis, Jeffrey A. Niezgoda, Rajagopalan Sridhar
-
Patent number: 11103427Abstract: The present invention has as its object the provision of an aerosol composition for hair which has excellent deodorization effect and silky feeling and in which a powder hardly floats at an applied area, and an aerosol product for hair. An aerosol composition for hair of the present invention is characterized by comprising: 2 to 7% by mass of an oil absorbing powder having an oil absorption of 0.45 to 0.75 ml/g; 0.1 to 0.6% by mass of a polyol; 3 to 33% by mass of a lower alcohol; and 65 to 94% by mass of a hydrocarbon having 3 to 5 carbon atoms which has a vapor pressure of 0.05 to 0.35 MPa at a temperature of 20° C.; and containing no surfactant. An aerosol product for hair of the present invention is characterized by comprising the aerosol composition for hair filled in an aerosol container which is a pressure-resistant container having an aerosol valve, and in that the discharge amount is 0.3 to 1.2 g/second.Type: GrantFiled: September 18, 2019Date of Patent: August 31, 2021Assignee: TOYO AEROSOL INDUSTRY CO., LTD.Inventor: Makoto Tsubouchi
-
Patent number: 11096962Abstract: The present invention relates to the field of human health and more particularly concerns nanoparticles for use as a therapeutic vaccine in the context of radiotherapy in a subject suffering of a cancer, in particular of a metastatic cancer or of a liquid cancer.Type: GrantFiled: May 27, 2016Date of Patent: August 24, 2021Assignee: NANOBIOTIXInventors: Julie Marill, Agnes Pottier, Laurent Levy
-
Patent number: 11097034Abstract: A method of modulating transdifferentiation of chondrocytes to osteoblast includes administering to the chondrocytes an agent that modulates GP130 receptor signaling and expression of at least one of Sox2, Oct4, or Nanog of the chondrocytes.Type: GrantFiled: December 11, 2017Date of Patent: August 24, 2021Assignees: CASE WESTERN RESERVE UNIVERSITY, THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Eben Alsberg, Oju Jeon, Ralph Marcucio, Chelsea Bahney, Diane Hu, Sarah Knox
-
Patent number: 11090238Abstract: An array of cosmetic compositions intended to camouflage imperfections on human skin in a targeted manner is provided. The array includes two or more different cosmetic compositions, each cosmetic composition having a metal oxide. The different cosmetic compositions each have an L* value within the range of from about 60 to about 90. In addition, one or more of the cosmetic compositions from the array will effectively camouflage imperfections on a consumer's skin if they have an average skin L* value between 35 and 75.Type: GrantFiled: June 13, 2018Date of Patent: August 17, 2021Assignee: The Procter & Gamble CompanyInventors: Thomas Elliott Rabe, Janette Villalobos Lingoes, Lissette D Schorsch, Tim Nolan
-
Patent number: 11090250Abstract: Personal care products are provided. An exemplary personal care product includes a composition that is applied to the body or clothing, or an article applied against the body; a plurality of particles associated with the composition or a component of the article, the plurality of particles, at least some of the plurality of particles comprising a cyclodextrin complexing material and a first fragrance material, wherein the percent of the first fragrance material that is complexed with the cyclodextrin is greater than about 90%, so that the perceptibility of the first fragrance is minimized prior to its release; and a second fragrance material that is not complexed with the cyclodextrin and that is different from the first fragrance material, wherein the composition or article does not contain an antiperspirant active.Type: GrantFiled: November 8, 2018Date of Patent: August 17, 2021Assignee: The Procter & Gamble CompanyInventors: Timothy Alan Scavone, Michael Jude Leblanc, Lowell Alan Sanker, Adrian Gregory Switzer
-
Patent number: 11078181Abstract: A compound represented by the following Formula (I) or a salt thereof, as well as a formulation for controlling harmful organisms, and in particular, an insecticidal formulation, a miticidal formulation, a formulation for controlling ectoparasites or a formulation for controlling or killing endoparasites, which contains at least one compound selected from the compounds of Formula (I) and salts thereof as an active ingredient wherein, each of R1 and R2 independently represents a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, or the like, with the proviso that when R2 represents a hydrogen atom, R1 represents a substituted or unsubstituted C6-10 aryl group or a substituted or unsubstituted 3- to 6-membered heterocyclyl group; R3 represents a C1-6 alkylthio group or the like; each of R4 and R5 independently represents a hydrogen atom, a halogeno group or the like; and Ar represents a substituted or unsubstituted C6-10 aryl group, or a substituted or unsubstituted 5- to 6-membered heteroarylType: GrantFiled: December 14, 2017Date of Patent: August 3, 2021Assignee: Nippon Soda Co., Ltd.Inventors: Keita Sakanishi, Takao Iwasa, Norifumi Sakiyama, Hikaru Aoyama, Tomomi Kobayashi
-
Patent number: 11077112Abstract: The invention relates to pharmaceutical compositions comprising 6-thioguanidine (6-TG) wherein the composition is formulated for release of 6-TG in the distal intestine. Methods for treating a disease or condition of the distal ileum that responds to 6-TG wherein the 6-TG is released in the distal intestine are also disclosed.Type: GrantFiled: September 29, 2016Date of Patent: August 3, 2021Assignee: PRODRUGXTEND PTY LTDInventors: Timothy Florin, Amirali Popat, Siddharth Jambhrunkar
-
Patent number: 11077061Abstract: Oral preparations of microcapsules and nanoparticles including an inhibitor of the mammalian target of rapamycin. The preparations are intended to assist with the treatment and prevention of cancer, neurocognitive dysfunction, genetically predisposed disorders, and age-related disorders. The embodiments discussed address the present need for alternative preparations or manufacturing processes that ensure efficacy while improving other performance characteristics such as storage stability, biodistribution, dosage cost, etc.Type: GrantFiled: July 31, 2019Date of Patent: August 3, 2021Assignee: Rapamycin Holdings, Inc.Inventors: Dana Vaughn, Neal K. Vail
-
Patent number: 11077124Abstract: A pharmaceutical composition for inhalation comprising R (+) budesonide and one or more bronchodilators, and, optionally, one or more pharmaceutically acceptable excipients is described.Type: GrantFiled: July 10, 2017Date of Patent: August 3, 2021Assignee: CIPLA LimitedInventors: Geena Malhotra, Shrinivas Madhukar Purandare, Amar Lulla
-
Patent number: 11071742Abstract: This invention relates to methods and compositions for use improving cell viability, particularly neural cell viability, and more particularly to methods and compositions for use improving cell viability by reducing reactive oxygen metabolite-mediated oxidative damage in a cell, regulating redox homeostasis in a cell, or reducing mitochondrial dysfunction in a cell. The invention further relates to the administration of the bile acid tauroursodeoxycholic acid (TUDCA) in combination with phenylbutyric Acid (PBA) to improve cell viability, and treat at least one symptom associated with, prevent the time of onset of, or slow the development of a disease related to oxidative stress.Type: GrantFiled: February 20, 2019Date of Patent: July 27, 2021Assignee: Amylyx Pharmaceuticals Inc.Inventors: Joshua Cohen, Justin Klee
-
Patent number: 11065123Abstract: Provided is a compression resistant implant configured to fit at or near a bone defect to promote bone growth, the compression resistant implant comprising porous ceramic particles in a biodegradable polymer, and an oxysterol disposed in or on the compression resistant implant. Methods of making and use are further provided.Type: GrantFiled: June 22, 2020Date of Patent: July 20, 2021Assignee: Warsaw Orthopedic, Inc.Inventors: Benjamin T. Reves, David S. Scher, Susan J. Drapeau, Roger E. Harrington, Jerbrena C. Jacobs